The typical methods for the clinical diagnosis of the BRAF V600E mutation in CRC are immunohistochemistry (IHC) in conjunction with microscopy [8], polymerase chain reaction (PCR) [9], and gene sequencing [10]. Here, BRAF is linked to colorectal carcinoma.